NIH-funded research R01 grant

Understanding how Staphylococcus aureus affects vaccine effectiveness

Official title: Mechanisms of vaccine interference by S. aureus-induced imprints

Funded at University of California, San Diego · NIH-11051233 · Data updated 2026-11-12

This study is looking into why vaccines for a common bacteria called Staphylococcus aureus don't work as well in people as they do in animals, and it hopes to find ways to make these vaccines more effective by understanding how our immune system reacts to the bacteria.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startMarch 6, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$714,925
NIH project number5R01AI179098-02
Project IDNIH-11051233 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have had recurrent Staphylococcus aureus infections or are at high risk for such infections.

Less likely to help

Patients who have never been exposed to Staphylococcus aureus or those with unrelated health conditions may not benefit from this research.

What this research studies

This research investigates why vaccines targeting Staphylococcus aureus often fail in humans despite success in animal models. It focuses on the immune response to the bacteria, particularly how prior exposure to Staphylococcus aureus alters antibody production and effectiveness. By studying the role of a specific immune molecule called IL10, the research aims to uncover the mechanisms behind these vaccine failures and identify potential strategies to improve vaccine responses in humans.

Why it matters

Potential benefit: If successful, this research could lead to more effective vaccines against Staphylococcus aureus, reducing infections and antibiotic resistance.

How similar studies have gone: Previous research has shown that understanding immune responses can lead to breakthroughs in vaccine development, suggesting potential success for this approach.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Liu, George Y — University of California, San Diego
  • Study coordinator: Liu, George Y

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.